Andrew Zloza, MD, PhD

Congrats to our (@amarzo67) student @prestondaniels_ for completing this PhD studies with the publication of this manuscript describing another way that the intratumoral #Influenza #Vaccine reduces breast cancer growth. mdpi.com/2611896 #mdpiijms via @IJMS_MDPI @RushDOIM

Very honored to be starting a new faculty position in the Department of Surgery at the University of Texas Medical Branch (UTMB) in Galveston! Thanks to all those who made this transition possible! @utmbhealth @JochenReiser @KlimbergV @UTMBSurgery

This team science paper offers a mechanism for diabetic kidney disease. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease | Science Translational Medicine ⁦@salimhayek⁩ ⁦@KeZhu3304⁩ ⁦@ASNKidney⁩ science.org/doi/10.1126/sc…

Meet the Author: Dr. Andrew Zloza (@AndrewZloza), an Associate Professor from @RushDOIM, @RushUniversity, @RushMedical, & senior author of “Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer,” out in #JITC! 1/6

It’s a wrap ! 11 years ⁦⁦@RushMedical⁩ ! I have fond memories and hopefully have created lasting impact ⁦@RushDOIM⁩. It has been a privilege to lead our outstanding Department of Medicine. Thank you !

Huge congratulations @JochenReiser on establishing and leaving a legacy of a thriving Dept of Medicine @ Rush and beginning an even more ambitious new journey @ utmb. 👏👏👏

Congrats @salimhayek @JochenReiser and team on a fabulous new study further linking extrarenal innate immune activation with glomerular injury and pathology. Very cool mechanism! 👏👏👏

Cracking down on cancers ! Great work by @AndrewZlozaand colleagues. Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory c… pubmed.ncbi.nlm.nih.gov/37433716/

Here is a deeper look at recent #JITC publication: “Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer” 1/5

Much thanks to the organizers of the @harvardmed @BrighamWomens “Skin Inflammation in Human Health and Disease 2023 International Conference” & especially to Rachael Clark for the invite! It was a great in-person experience, awesome audience, & well worth the COVID-delayed wait.

New #JITC article: Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer bit.ly/46OqtqP @sachinrjhawar @Praveen_IO @HowardK39084949 @AndrewZloza

Much thanks to @NorthwesternMed @NUFeinbergMed Department of Microbiology-Immunology and Andrew Cogswell for hosting me last week! Great audience during my seminar with superb questions and wonderful faculty meetings!

Congratulations, Dr. Reiser!! @JochenReiser @RushMedical

Amazing news! So well-deserved for @JochenReiser at @RushMedical and such a great new leader for @utmbhealth. Best wishes from everyone! @ASNKidney @dgfn_ev @the_asci utsystem.edu/news/2023/04/2…

This pretty much sums it all up.

The latest edition of the #JITC Reading List is out. Social Media Editor Dr. Praveen K. Bommareddy (@Praveen_IO) selects articles that add value to what readers find in the Journal for ImmunoTherapy of Cancer. Enjoy articles from the #immunotherapy field ow.ly/GGuT50E1wuG

@DelgoffeLab @BReinfeld @jitcancer @JimAllisonPhD @PamSharmaMDPhD @PatrickHwuMD Thanks @DelgoffeLab - I almost missed this! – & yes, Coley had the right idea – now we are trying to implement “bugs as drugs” as cancer IT (jitc.bmj.com/content/6/1/3) – with the flu season approaching, maybe tumors could benefit from an i.t. flu shot!? (pnas.org/doi/10.1073/pn…)

@BReinfeld @jitcancer @JimAllisonPhD @PamSharmaMDPhD @PatrickHwuMD @AndrewZloza probably has a lot to say about this!

New #JITC case report: Exceptional response to PD-1 inhibition immunotherapy in advanced metastatic osteosarcoma with tumor site infection bit.ly/3DhJ2rb

I am thrilled to announce that the Schenkel Lab will open it’s doors on Sept 15th @MDAndersonNews @MDA_UTHGrad. This is the culmination of many years of blood, sweat, and tears. I am over the moon excited to join such an incredible group of people focused on #endcancer. 1/

I am forever indebted to those who have taken me under their wing. @AndrewZloza for introducing me to Immunology, and sending me down an entirely different life path. Without your guidance, who knows where I would have ended up. Maybe back in New Jersey. 3/

Having previously shown that an intratumoural injection of a commercially available seasonal influenza vaccination can turn cold tumors into hot tumors, @KajalGupta04 has now looked into the potential antitumor effects of the inactivated SARS-CoV-2 virus: biorxiv.org/content/10.110…